VYNE Therapeutics (NASDAQ: VYNE)
$0.32
(-2.4%)
-$0.01
Price as of August 26, 2025, 4:00 p.m. ET
VYNE Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
VYNE Therapeutics Company Info
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded on October 21, and is headquartered in Bridgewater, NJ.
News & Analysis
Valuation
Earnings Transcripts
VYNE Therapeutics Inc. (VYNE) Q2 2021 Earnings Call Transcript
VYNE earnings call for the period ending June 30, 2021.
Motley Fool Transcribing | Aug 13, 2021
VYNE Therapeutics Inc. (VYNE) Q1 2021 Earnings Call Transcript
VYNE earnings call for the period ending March 31, 2021.
Motley Fool Transcribing | May 7, 2021
VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript
VYNE earnings call for the period ending December 31, 2020.
Motley Fool Transcribing | Mar 4, 2021
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.